Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€238.20
12.12.21
-
12.12.22
-4.28%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
-
12.12.22
-3.13%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€180.00
12.12.22
-32.76%
13.12.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
MoneyMoney 
12.12.21 0%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.22
12.12.21
-
12.12.22
1.64%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.63
12.12.21
-
12.12.22
-6.36%
22.12.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Mori8 
12.12.21 50%
buy
G6 Materials Corp.

Start price
Target price
Perf. (%)
€0.66
12.12.21
-
12.12.22
1.52%
11.01.22

Mori8 
12.12.21 50%
buy
Encavis AG

Start price
Target price
Perf. (%)
€15.25
12.12.21
€17.00
12.12.22
3.61%
25.12.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
Ellritze 
12.12.21 70%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€260.00
12.12.22
-3.13%
25.12.21

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Ellritze 
12.12.21 70%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€238.20
12.12.21
€260.00
12.12.22
-4.28%
25.12.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Ellritze 
12.12.21 70%
sell
Celon Pharma S.a.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-7.31%
26.01.22

Probably not worthwhile Investment
tinelchen 
12.12.21 0%
sell
Algernon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.83
12.12.21
-
12.12.22
-12.65%
30.12.21

Probably not worthwhile Investment
tinelchen 
12.12.21 0%
buy
Daimler Truck Holding AG

Start price
Target price
Perf. (%)
€32.61
12.12.21
-
12.12.22
-5.83%
13.12.22

Lutz69 
12.12.21 50%
buy
GSW Immobilien AG

Start price
Target price
Perf. (%)
€114.00
11.12.21
€166.00
11.12.22
-20.70%
12.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
kostojunior 
11.12.21 0%
buy
Gesco AG NA

Start price
Target price
Perf. (%)
€25.00
11.12.21
€33.00
11.12.22
-3.60%
12.12.22

Revenue growth > 30% per year expected
Top 10 in its market
Could be worthwhile Investment >10% per year
Innovative
kostojunior 
11.12.21 70%
buy
Orbis AG

Start price
Target price
Perf. (%)
€7.80
11.12.21
€9.00
11.12.22
-11.54%
12.12.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
kostojunior 
11.12.21 77%
buy
Sociedad Quimica y Minera de Chile SA ADR

Start price
Target price
Perf. (%)
€52.00
11.12.21
€65.00
11.12.22
-14.23%
25.12.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
skatcup 
11.12.21 100%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
11.12.21 100%
buy
Mercadolibre Inc

Start price
Target price
Perf. (%)
€1,021.0
11.12.21
€1,470.0
11.12.22
-17.24%
12.12.22

Could be worthwhile Investment >10% per year
melinda 
11.12.21 50%
buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€39.97
11.12.21
€43.00
11.12.22
-64.71%
12.12.22

Could be worthwhile Investment >10% per year
melinda 
11.12.21 50%
buy
Intuit Inc.

Start price
Target price
Perf. (%)
€608.50
11.12.21
€605.00
11.12.22
-30.15%
20.02.22

Traumtanz 
11.12.21 60%
buy
Mastercard Inc. A

Start price
Target price
Perf. (%)
€310.00
11.12.21
€350.00
11.12.22
6.94%
05.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Future proof or reliable business model
Traumtanz 
11.12.21 80%